Abstract
Basal cell carcinomas are the most common malignant skin tumors. The clinical aspect underlying this type of tumor ranges from millimeter lesions to large, ulcerated tumors. Although surgery remains the gold standard of treatment for most of the high-risk tumors, recent nonsurgical and topical therapies, used in mono- or combination therapy have offered a new perspective in the treatment of basal cell carcinoma. Causes related to patient's associated pathology, location and tumor characteristics, recovery times, costs, and patient's desire have led to the exploration of other treatment options. In this paper we propose to revise the current indications for treatment of basal cell carcinomas, the international experience of combined therapies as it appears from articles published in specialized journals. Key words: basal cell carcinoma, topical therapies, combined therapies, laser, surgery. Cite this article : Alina Suru, Ionela Manole, George Sorin Ţiplica, Carmen Maria Salavastru. Basal cell carcinoma: when excision is not an option. RoJCED 2017;3(4):130-133. https://doi.org/10.26574/rojced.2017.4.3.130
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
